Top

Published in:

01-01-2009 | Pediatric

Pediatric liver tumors – a pictorial review

Authors: Priyanka Jha, Soni C. Chawla, Sidhartha Tavri, Chirag Patel, Charles Gooding, Heike Daldrup-Link

Published in: European Radiology | Issue 1/2009

Abstract

Hepatic masses constitute about 5–6% of all intra-abdominal masses in children. The majority of liver tumors in children are malignant; these malignant liver tumors constitute the third most common intra-abdominal malignancy in the pediatric age group after Wilms’ tumor and neuroblastoma. Only about one third of the liver tumors are benign. A differential diagnosis of liver tumors in children can be obtained based on the age of the child, clinical information (in particular AFP) and imaging characteristics. The purpose of this review is to report typical clinical and imaging characteristics of benign and malignant primary liver tumors in children.

Kuhn JP, Slovis TL, Haller JO, Caffey J (eds) (2004) Caffey’s pediatric diagnostic imaging, 10th edn. Mosby, Philadelphia

Helmberger TK, Ros PR, Mergo PJ et al (1999) Pediatric liver neoplasms: a radiologic-pathologic correlation. Eur Radiol 9:1339–1347PubMedCrossRef

Emre S, McKenna GJ (2004) Liver tumors in children. Pediatr Transplant 8:632–638PubMedCrossRef

Szymik-Kantorowicz S, Partyka L, Dembinska-Kiec A et al (2003) Vascular endothelial growth factor in monitoring therapy of hepatic haemangioendothelioma. Med Pediatr Oncol 40:196–197PubMedCrossRef

Ayling RM, Davenport M, Hadzic N et al (2001) Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor. J Pediatr 138:932–935PubMedCrossRef

Schneider G, Grazioli L, Saini S (eds) (2003) MRI of the liver: imaging techniques, contrast enhancement, differential diagnosis. Springer, Milan, New York, p 214

Stringer MD, Alizai NK (2005) Mesenchymal hamartoma of the liver: a systematic review. J Pediatr Surg 40:1681–1690PubMedCrossRef

Chang HJ, Jin SY, Park C et al (2006) Mesenchymal hamartomas of the liver: comparison of clinicopathologic features between cystic and solid forms. J Korean Med Sci 21:63–68PubMedCrossRef

Bartolotta TV, Midiri M, Galia M et al (2001) Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media. Radiol Med (Torino) 101:219–229

10.

Beets-Tan RG, Van Engelshoven JM, Greve JW (1998) Hepatic adenoma and focal nodular hyperplasia: MR findings with superparamagnetic iron oxide-enhanced MRI. Clin Imaging 22:211–215PubMedCrossRef

11.

Kim MJ, Kim JH, Lim JS et al (2004) Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 20:612–621PubMedCrossRef

12.

Mergo PJ, Engelken JD, Helmberger T et al (1998) MRI in focal liver disease: a comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents. J Magn Reson Imaging 8:1073–1078

13.

Urhahn R, Adam G, Busch N et al (1996) Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions? Rofo 165:364–370PubMed

14.

Pena CS, Saini S, Baron RL et al (2001) Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial. Korean J Radiol 2:210–215PubMedCrossRef

15.

Frohlich JM (2004) MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. J Magn Reson Imaging 19:375–376 author reply 376PubMedCrossRef

16.

Grazioli L, Morana G, Kirchin MA et al (2003) MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. J Magn Reson Imaging 17:593–602PubMedCrossRef

17.

Maruyama K, Ikeda H, Koizumi T et al (2000) Case-control study of perinatal factors and hepatoblastoma in children with an extremely low birthweight. Pediatr Int 42:492–498PubMedCrossRef

18.

Tanimoto A, Kuwatsuru R, Kadoya M et al (1999) Evaluation of gadobenate dimeglumine in hepatocellular carcinoma: results from phase II and phase III clinical trials in Japan. J Magn Reson Imaging 10:450–460PubMedCrossRef

19.

Hamm B, Kirchin M, Pirovano G et al (1999) Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: results of multicenter studies in Europe and the USA. J Comput Assist Tomogr 23(Suppl 1):S53–S60PubMed

20.

Lauwers GY, Grant LD, Donnelly WH et al (1997) Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Am J Surg Pathol 21:1248–1254PubMedCrossRef

21.

O'Sullivan MJ, Swanson PE, Knoll J et al (2001) Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: report of a case and review of the literature. Pediatr Dev Pathol 4:482–489PubMedCrossRef

22.

Ramanujam TM, Ramesh JC, Goh DW et al (1999) Malignant transformation of mesenchymal hamartoma of the liver: case report and review of the literature. J Pediatr Surg 34:1684–1686PubMedCrossRef

23.

Craig JR (1994) Mesenchymal tumors of the liver. Diagnostic problems for the surgical pathologist. Pathology (Phila) 3:141–160

24.

Boechat MI, Kangarloo H (1989) MR imaging of the abdomen in children. AJR Am J Roentgenol 152:1245–1250PubMed

25.

White KS (1996) Reduced need for sedation in patients undergoing helical CT of the chest and abdomen. Pediatr Radiol 26:5PubMedCrossRef

26.

Paterson A, Frush DP, Donnelly LF (2001) Helical CT of the body: are settings adjusted for pediatric patients? AJR Am J Roentgenol 176:297–301PubMed

27.

Frush DP, Slack CC, Hollingsworth CL et al (2002) Computer-simulated radiation dose reduction for abdominal multidetector CT of pediatric patients. AJR Am J Roentgenol 179:1107–1113PubMed

28.

Slovis TL (2003) Children, computed tomography radiation dose, and the As Low As Reasonably Achievable (ALARA) concept. Pediatrics 112:971–972PubMedCrossRef

29.

da Costa e Silva EJ, da Silva GA (2007) Eliminating unenhanced CT when evaluating abdominal neoplasms in children. AJR Am J Roentgenol 189:1211–1214PubMedCrossRef

30.

Frush DP, Donnelly LF (1998) Helical CT in children: technical considerations and body applications. Radiology 209:37–48PubMed

31.

Vade A, Demos TC, Olson MC et al (1996) Evaluation of image quality using 1:1 pitch and 1.5:1 pitch helical CT in children: a comparative study. Pediatr Radiol 26:891PubMedCrossRef

32.

Vade A, Olson MC, Vittore CP et al (1999) Hepatic enhancement analysis in children using Smart Prep monitoring for 2:1 pitch helical scanning. Pediatr Radiol 29:689–693PubMedCrossRef

33.

Roche KJ, Genieser NB, Ambrosino MM (1996) Pediatric hepatic CT: An injection protocol. Pediatr Radiol 26:502–507PubMedCrossRef

34.

Ruess L, Bulas DI, Kushner DC et al (1998) Peak enhancement of the liver in children using power injection and helical CT. AJR Am J Roentgenol 170:677–681PubMed

35.

Haliloglu M, Hoffer FA, Gronemeyer SA et al (2000) Three dimensional gadolinium-enhanced MR angiography evaluation of hepatic vasculature in children with hepatoblastoma. J Magn Reson Imaging 11

36.

Teo EHJ, Strouse PJ, Prince MR (1999) Applications of magnetic resonance imaging and magnetic resonance angiography to evaluatge the hepatic vasculature in the pediatric patient. Pediatr Radiol 29:238–243PubMedCrossRef

37.

Rawsin JV, Seigel MJ (1996) Techniques and strategies in pediatric body MR imaging. Magn Reson Imaging Clin North Am 4:589–598

38.

Gillies RJ, Morse DL (2005) In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng 7:287–326PubMedCrossRef

39.

Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC (2004) In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging 19:598–604PubMedCrossRef

40.

Li CW, Kuo YC, Chen CY et al (2005) Quantification of choline compounds in human hepatic tumors by proton MR spectroscopy at 3 T. Magn Reson Med 53:770–776PubMedCrossRef

41.

Weiner MW, Hetherington H, Hubesch B et al (1989) Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney, and cancer. A quantitative approach. NMR Biomed 2:290–297PubMedCrossRef

42.

Bell JD, Bhakoo KK (1998) Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours. NMR Biomed 11:354–359PubMedCrossRef

43.

Foley WD, Bree RL, Gay SB et al (2006) ACR Appropriateness Criteria for liver lesion characterization. American College of Radiology, Reston. Available via http://acsearch.acr.org/VariantList.aspx?topicid=30663. Accessed 31st March 2008

Title: Pediatric liver tumors – a pictorial review
Authors: Priyanka Jha
Soni C. Chawla
Sidhartha Tavri
Chirag Patel
Charles Gooding
Heike Daldrup-Link
Publication date: 01-01-2009
Publisher: Springer-Verlag
Published in: European Radiology / Issue 1/2009
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-008-1106-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Pediatric liver tumors – a pictorial review

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2009

Characterization of pediatric head and neck masses with diffusion-weighted MR imaging

Reply to: enteroclysis vs enterography: the unsettled issue

Can abdominal multi-detector CT diagnose spinal osteoporosis?

Prevalence and correlates of pulmonary emphysema in smokers and former smokers. A densitometric study of participants in the ITALUNG trial

2D and 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy with erectile function correlation

Use of dynamic CT in acute respiratory distress syndrome (ARDS) with comparison of positive and negative pressure ventilation